Allogene Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $582k | 181k | 3.21 |
| 2023-09-30 | $655k | 207k | 3.17 |
| 2023-06-30 | $1.5M | 297k | 4.96 |
| 2023-03-31 | $1.1M | 233k | 4.94 |
| 2022-12-31 | $855k | 136k | 6.29 |
| 2022-09-30 | $2.0M | 182k | 11.16 |
| 2022-06-30 | $1.6M | 137k | 11.37 |
| 2022-03-31 | $2.0M | 223k | 8.96 |
| 2021-12-31 | $2.4M | 158k | 14.98 |
| 2021-09-30 | $4.5M | 173k | 25.83 |
| 2021-06-30 | $1.0M | 38k | 26.11 |
| 2021-03-31 | $3.0M | 86k | 35.31 |
| 2020-12-31 | $35k | 1.2k | 28.17 |
| 2020-09-30 | $54k | 1.4k | 37.54 |
| 2020-06-30 | $128k | 3.0k | 42.99 |
| 2020-03-31 | $62k | 3.2k | 19.69 |
| 2019-12-31 | $60k | 2.3k | 25.84 |
| 2019-09-30 | $108k | 3.9k | 27.41 |
| 2019-06-30 | $1.6M | 61k | 26.92 |
| 2019-03-31 | $268k | 9.3k | 28.94 |
| 2018-12-31 | $81k | 3.0k | 26.80 |